Sales results disclosed Tuesday raised concern that investors may have overestimated the demand for Zepbound and Mounjaro.
Medical experts proposed a radical overhaul of how obesity is diagnosed, moving away from relying on body mass alone and ...
Fourth-quarter earnings at JPMorgan Chase, Wells Fargo, Goldman Sachs, and Citigroup beat analysts’ estimates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback